ChartRow logo
PeersAJGAONBROWTWCBERIE
Share this page

MRSH financial statements

The full income statement, balance sheet, and cash-flow statement for Marsh (MRSH), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +9.4%5Y CAGR +9.4%YoY +8.1%
$28.5B TTM$6.9B Q3 '26
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +15.2%10Y CAGR +11.0%YoY +3.8%
$6.1B TTM$1.2B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR +15.6%10Y CAGR +10.0%YoY +8.2%
$4B TTM$808M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +16.4%10Y CAGR +11.0%YoY +11.9%
$8.34 TTM$1.69 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y CAGR +9.4%10Y CAGR +10.9%YoY −29.0%
$4.5B TTM$1.5B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR −3.5%10Y CAGR −1.1%YoY +12.5%
$320M TTM$81M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +10.5%10Y CAGR +12.3%YoY −30.5%
$4.2B TTM$1.4B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y −3.5%10Y −7.8%YoY −3.0%
484.5M TTM479M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR +13.1%10Y CAGR +11.0%YoY +10.0%
$3.78 TTM$1.98 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares outstanding (point-in-time)

2024-09 491.1M2024-12 491.1M2025-03 492.7M2025-06 491.6M2025-09 489.9M2025-12 484.1M2026-03 481.8M2026-06 477.2M2026-09 475.5M-3.2% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue27.0B+10.3%24.5B+7.6%22.7B+9.7%20.7B+4.5%19.8B+15.1%
20.8B+11.4%18.6B+6.8%17.5B+6.2%16.4B+6.0%15.5B+9.5%
Restructuring222M-19.6%276M-8.3%301M-29.5%427M+510.0%70.0M-21.3%
Amortization of intangibles549M+45.6%377M+9.9%343M+1.5%338M-7.4%365M+4.0%
Provision for credit losses25.0M-19.4%31.0M+82.4%17.0M+0.0%17.0M-63.0%46.0M-2.1%
Operating income6.22B+7.0%5.82B+10.1%5.28B+23.4%4.28B-0.7%4.31B+40.6%
Interest expense960M+37.1%700M+21.1%578M+23.2%469M+5.6%444M-13.8%
Interest & investment income48.0M-42.2%83.0M+6.4%78.0M+420.0%15.0M+650.0%2.00M-71.4%
Gain (loss) on equity securities——-1.00M-109.1%11.0M+120.0%5.00M
Pre-tax income5.54B+1.1%5.48B+9.0%5.03B+23.1%4.08B-3.0%4.21B+50.7%
Income tax1.30B-4.3%1.36B+11.4%1.22B+23.0%995M-3.8%1.03B+38.4%
4.16B+2.5%4.06B+8.1%3.76B+23.1%3.05B-3.0%3.14B+55.9%
Net income to non-controlling interest74.0M+29.8%57.0M+23.9%46.0M+24.3%37.0M+19.4%31.0M+3.3%
Net income to common4.16B+2.5%4.06B+8.1%3.76B+23.1%3.05B-3.0%3.14B+55.9%
$8.43+3.1%$8.18+8.6%$7.53+24.7%$6.04-1.5%$6.13+55.6%
EPS (basic)$8.48+2.7%$8.26+8.7%$7.60+24.4%$6.11-1.5%$6.20+55.8%
Weighted-avg shares (basic)491M-0.2%492M-0.4%494M-1.0%499M-1.6%507M+0.2%
Weighted-avg shares (diluted)494M-0.4%496M-0.6%499M-1.2%505M-1.6%513M+0.2%
Dividends per share$3.43+12.5%$3.05+17.3%$2.60+15.6%$2.25+10.3%$2.04+10.0%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
23.2B+4.9%22.1B+1.7%21.7B+14.7%19.0B+129.4%8.26B+1.3%
Cash & equivalents2.69B+12.1%2.40B-28.6%3.36B+132.9%1.44B-17.7%1.75B-16.1%
Accounts receivable7.67B+7.2%7.16B+11.5%6.42B+9.7%5.85B+4.8%5.59B+4.9%
Other current assets1.37B+6.4%1.29B+9.3%1.18B+17.2%1.00B+8.5%926M+25.1%
58.7B+3.9%56.5B+17.6%48.0B+8.9%44.1B+28.3%34.4B+4.1%
Property, plant & equipment829M-3.5%859M-2.6%882M+1.3%871M+2.8%847M-1.1%
Operating lease right-of-use1.46B-2.5%1.50B-2.8%1.54B-1.3%1.56B-16.4%1.87B-1.4%
Goodwill24.3B+4.4%23.3B+35.3%17.2B+6.0%16.3B-0.4%16.3B+5.2%
Intangible assets4.75B-1.5%4.82B+83.3%2.63B+3.7%2.54B-9.7%2.81B+4.1%
Deferred tax assets212M-10.5%237M-33.6%357M-0.3%358M-35.0%551M-21.5%
Other non-current assets1.79B+3.2%1.73B+8.8%1.59B+9.7%1.45B-0.8%1.46B+0.2%
21.1B+7.9%19.5B-1.4%19.8B+11.0%17.8B+168.0%6.65B+1.5%
Accrued liabilities3.65B+7.3%3.40B-0.0%3.40B+3.8%3.28B+3.6%3.17B+3.8%
Short-term & current debt1.27B+144.1%519M-67.9%1.62B+504.1%268M+1476.5%17.0M-96.7%
Current lease liability333M+2.5%325M+4.2%312M+0.6%310M-6.6%332M-2.9%
43.4B+1.0%42.9B+20.4%35.7B+6.9%33.4B+44.0%23.2B-2.6%
Long-term debt18.3B-5.7%19.4B+64.0%11.8B+5.5%11.2B+2.7%10.9B+1.3%
Non-current lease liability1.53B-3.8%1.59B-4.3%1.66B-0.4%1.67B-11.3%1.88B-2.3%
Operating lease liability (total)1.86B-2.8%1.92B-2.9%1.97B-0.2%1.98B-10.6%2.21B-2.4%
Other non-current liabilities1.41B+11.6%1.26B-0.2%1.27B-7.0%1.36B-20.4%1.71B+15.3%
15.1B+13.2%13.3B+9.4%12.2B+15.9%10.5B-4.4%11.0B+20.9%
Preferred stock0.000.000.000.000.00
Common stock561M+0.0%561M+0.0%561M+0.0%561M+0.0%561M+0.0%
Additional paid-in capital1.55B+12.9%1.37B+10.3%1.24B+5.3%1.18B+6.0%1.11B+17.9%
Retained earnings27.8B+9.7%25.3B+11.2%22.8B+12.1%20.3B+10.4%18.4B+13.0%
Treasury stock9.35B+22.1%7.66B+8.2%7.08B+14.0%6.21B+38.6%4.48B+25.7%
Accumulated other comprehensive income-5.43B+13.0%-6.24B-17.8%-5.29B+0.4%-5.31B-16.2%-4.58B+10.5%
Non-controlling interest215M+11.4%193M+7.8%179M-21.8%229M+7.5%213M+36.5%
Total equity incl. non-controlling15.3B+13.2%13.5B+9.4%12.4B+15.1%10.7B-4.2%11.2B+21.2%
Total liabilities & equity58.7B+3.9%56.5B+17.6%48.0B+8.9%44.1B+28.3%34.4B+4.1%
Common shares issued561M+0.0%561M+0.0%561M+0.0%561M+0.0%561M+0.0%
Common shares outstanding485M-1.2%491M-0.2%492M-0.6%495M-1.8%504M-0.8%
Shares outstanding (cover)484M-1.4%491M-0.1%492M-0.6%495M-1.6%503M-1.1%
Treasury shares75.8M+9.5%69.2M+0.9%68.6M+4.2%65.9M+15.3%57.1M+7.9%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
5.29B+23.0%4.30B+1.0%4.26B+22.9%3.46B-1.5%3.52B+4.0%
Depreciation & amortization910M+22.0%746M+4.6%713M-0.8%719M-3.7%747M+0.8%
Intangible amortization549M+45.6%377M+9.9%343M+1.5%338M-7.4%365M+4.0%
Share-based compensation394M+7.1%368M+1.4%363M-1.1%367M+5.5%348M+20.0%
Deferred income taxes123M-21.7%157M+641.4%-29.0M+32.6%-43.0M+31.7%-63.0M-257.5%
-845M+90.4%-8.82B-522.5%-1.42B-66.7%-850M+27.0%-1.16B-46.8%
Capital expenditure291M-7.9%316M-24.0%416M-11.5%470M+15.8%406M+16.7%
Free cash flow5.00B+25.5%3.99B+3.7%3.84B+28.3%3.00B-3.7%3.11B+2.5%
Acquisitions652M-92.4%8.54B+775.2%976M+70.6%572M-33.4%859M+32.8%
Other investing activities-2.00M-100.0%-1.00M+90.9%-11.0M-22.2%-9.00M-125.0%-4.00M-233.3%
-4.63B-204.0%4.46B+498.1%-1.12B-7.0%-1.05B+19.4%-1.30B-40.2%
Long-term debt issued0.00-100.0%8.17B+276.7%2.17B+120.4%984M+32.4%743M+0.8%
Long-term debt repaid519M-67.9%1.62B+507.9%266M-27.1%365M-64.1%1.02B-59.6%
Common stock issued0.000.000.000.000.00
Common stock repurchased2.01B+123.6%900M-21.7%1.15B-41.0%1.95B+68.2%1.16B
Dividends paid1.70B+12.3%1.51B+16.6%1.30B+14.1%1.14B+10.9%1.03B+8.8%
FX effect on cash673M+262.6%-414M-226.2%328M+139.0%-841M-136.9%-355M-169.5%
Net change in cash486M+201.7%-478M-123.3%2.05B+181.6%728M+4.0%700M-67.8%
Interest paid885M+49.7%591M+18.4%499M+15.8%431M-2.3%441M-8.3%
Income taxes paid1.29B+7.7%1.20B+9.1%1.10B+4.9%1.05B-1.9%1.07B+58.8%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap90.0B-13.7%104B+11.6%93.4B+13.8%82.1B-6.3%87.6B+47.4%
P/E21.6×-15.8%25.7×-4.7%27.0×+11.2%24.2×-13.1%27.9×-5.5%
P/S3.3×-21.8%4.3×+1.3%4.2×+6.8%3.9×-10.9%4.4×+28.1%
P/B6.0×-23.8%7.8×-4.6%8.2×-4.6%8.6×+7.8%8.0×+21.9%
P/FCF18.0×-31.2%26.2×+0.2%26.1×-7.7%28.3×+0.5%28.2×+43.8%
Earnings yield4.6%+18.8%3.9%+4.9%3.7%-10.1%4.1%+15.0%3.6%+5.8%
FCF yield5.6%+45.4%3.8%-0.2%3.8%+8.4%3.5%-0.5%3.6%-30.5%
Dividend yield1.8%+28.8%1.4%+4.6%1.4%+0.9%1.4%+15.8%1.2%-26.0%
Source filing10-K10-K10-K10-K10-K

About this data

Source: MRSH’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MRSH filings on SEC EDGAR → Not investment advice.